Table 3.
Clinical Comparison of APS Patients With and Without CVST.
| Parameters | APS with CVST (n = 21) | APS without CVST (n = 63) | P value |
|---|---|---|---|
| Gender (F/M) | 14/7 | 42/21 | 1.000 |
| Age, median (IQR) years | 33 (28-48) | 39 (28-50) | 0.521 |
| Disease duration, median (IQR) months | 1.3 (0.7-4) | 2 (0.5-12.2) | 0.616 |
| Secondary APS | 3 (14.3) | 9 (14.3) | 1.000 |
| Other thrombosis | 5 (23.8) | 30 (47.6) | 0.055 |
| HGB decreased | 5 (23.8) | 14 (22.2) | 1.000 |
| PLT decreased | 6 (28.6) | 12 (19.0) | 0.539 |
| D-dimer positive | 7 (33.3) | 23/59 (39.0) | 0.648 |
| ESR increased | 13 (61.9) | 27 (42.9) | 0.130 |
| ANAs positive | 8/18 (44.4) | 20/61 (32.8) | 0.364 |
| aCL positive | 10 (47.6) | 43 (68.3) | 0.090 |
| anti-β2GP-1 positive | 15/17 (88.2) | 53 (84.1) | 0.969 |